Showing results (251-260 of 410) with videos related to
Sort By:
Pageof 41
JCI Insight|June 5, 2020
Transcriptomic silencing as a potential mechanism of treatment resistanceJacob J Adashek, Shumei Kato, Rahul Parulkar, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 17, 2022
Low-dose CT from myocardial perfusion SPECT/CT allows the detection of anemia in preoperative patientsAntonio G Gennari, Hannes Grünig, Dominik C Benz, et al.Biochimica Et Biophysica Acta|August 17, 2002
Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosisUlrik B Nielsen, Dmitri B Kirpotin, Edward M Pickering, et al.Breast Cancer Research and Treatment|August 5, 2017
Tamoxifen therapy benefit for patients with 70-gene signature high and low riskLaura J van 't Veer, Christina Yau, Nancy Y Yu, et al.Expert Opinion on Therapeutic Targets|July 23, 2004
Development of ligand-targeted liposomes for cancer therapyCharles O Noble, Dmitri B Kirpotin, Mark E Hayes, et al.Biochemistry|October 22, 2024
Noncovalent Inhibition and Covalent Inactivation of Proline Dehydrogenase by Analogs of N-PropargylglycineJohn J Tanner, Juan Ji, Alexandra N Bogner, et al.Archives of Biochemistry and Biophysics|January 27, 2025
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenaseKaylen R Meeks, Juan Ji, Gary K Scott, et al.Oncotarget|November 16, 2017
ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibitionGary K Scott, David Chu, Ravneet Kaur, et al.Cancer Research|July 5, 2006
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsDmitri B Kirpotin, Daryl C Drummond, Yi Shao, et al.International Journal of Cardiology|April 17, 2018
Impact of cardiac hybrid imaging-guided patient management on clinical long-term outcomeDominik C Benz, Lara Gaemperli, Christoph Gräni, et al.Pageof 41